Secretory component: A potential regulator of endometrial-decidual prostaglandin production in early human pregnancy - 05/09/11
Abstract |
Objective: We sought to investigate the production of secretory component, an inhibitor of phospholipase A2, and prostaglandins by human endometrium-decidua. Study Design: The production of secretory component and prostaglandins by explants and dispersed glandular and stromal cells of secretory endometrium and first-trimester and term decidua were measured by enzyme-linked immunosorbent assay and radioimmunoassay, respectively. Results: Explants of first-trimester decidua produced significantly more secretory component and less prostaglandins than secretory endometrium. Immunohistochemical studies localized secretory component to epithelial glandular cells. At term, when fewer glandular cells are present, both secretory component and prostaglandin production were low. Exposure of first-trimester decidua to progesterone significantly increased secretory component production. Conclusion: Secretory component and prostaglandins localize primarily to epithelial glandular cells in endometrium-decidua, and their production appears to be inversely correlated. The increase in secretory component by first-trimester decidua after progesterone stimulation may account for the down-regulation of endometrial prostaglandin synthesis after implantation, a process thought to be necessary for pregnancy success. (Am J Obstet Gynecol 2000;183:108-17.)
Le texte complet de cet article est disponible en PDF.Keywords : Pregnancy, prostaglandin, secretory component, gravidin, immunoglobulin A
Plan
| ☆ | Supported in part by the Reproductive Scientist Development Program through National Institutes of Health grant 5K12-HD00849 and the Association of Professors of Gynecology and Obstetrics (Errol R. Norwitz, MD, PhD) and by grants from Birthright and the Scottish Home and Health Department (Theresa Wilson, PhD). |
| ☆☆ | Reprint requests: Errol R. Norwitz, MD, PhD, Assistant Professor, Harvard Medical School, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham & Women’s Hospital, 75 Francis St, Boston, MA 02115. |
Vol 183 - N° 1
P. 108-117 - juillet 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
